How live stem cells power real regeneration
Stem Cell Viability: Why Live Cell Counts Matter
Conditions We Treat
-
Osteoarthritis
-
Rheumatoid Arthritis
-
Psoriatic Arthritis
-
Neuropathy
-
Chronic Pain
-
Long COVID
-
Multiple Sclerosis
-
COPD
-
Autoimmune Conditions
These are just a few of the conditions we address with regenerative therapy.
See the Full List of Conditions We Treat
Why Stem Cell Viability is the Cornerstone of Effective Regenerative Treatment
When it comes to regenerative medicine, not all stem cell treatments are created equal. What truly determines therapeutic impact isn’t just how many cells are injected — it’s how many of those cells are alive and functional at the time of treatment. This concept, known as stem cell viability, is the cornerstone of any effective therapy.
At Stem Cell Therapy Experts, we don’t just promise high cell counts — we verify them. With viability rates regularly at or above 94%, our treatments aim to deliver the full regenerative capacity your body needs to repair, recover, and restore.
What is Stem Cell Viability — and Why It Matters
Stem cell viability refers to the percentage of living, functional cells in a given dose. These are the cells that interact with your body’s immune system, release growth factors, and stimulate tissue repair. For example, if you’re told you’re receiving 10 million stem cells but the viability is only 50%, you’re only getting 5 million live cells — which may fall below the threshold required to produce clinical benefits.
Certain conditions, such as autoimmune disease, neurodegeneration, or joint degeneration, require a robust number of active cells to produce results. Dead or non-functional cells provide no therapeutic value and can even place an unnecessary burden on your immune system.
The key takeaway: the therapeutic dose is defined not by what’s on the label, but by how many viable cells reach your body.
How We Confirm High Viability — Every Time
Verification of cell viability is not optional at SCTE — it is built into our clinical protocol. Every stem cell batch is tested using an automated digital cell counter immediately before administration. This advanced imaging and dye-exclusion system provides an accurate measure of live versus dead cells.
Patients receive a printed certificate or real-time visual of their viability results, often showing numbers as high as 94% or above. In fact, we frequently overdeliver — providing 110 million cells when 100 million are promised — to account for any potential cell loss during preparation.
This level of transparency is rare, but critical. It’s how we maintain integrity and ensure each patient receives an effective dose.
How We Confirm High Viability — Every Time
Verification of cell viability is not optional at SCTE — it is built into our clinical protocol. Every stem cell batch is tested using an automated digital cell counter immediately before administration. This advanced imaging and dye-exclusion system provides an accurate measure of live versus dead cells.
Patients receive a printed certificate or real-time visual of their viability results, often showing numbers as high as 94% or above. In fact, we frequently overdeliver — providing 110 million cells when 100 million are promised — to account for any potential cell loss during preparation.
This level of transparency is rare, but critical. It’s how we maintain integrity and ensure each patient receives an effective dose.
Industry Benchmarks — and Why We Surpass Them
Most clinics rely on cryopreserved stem cells that can suffer from lower viability rates — often as low as 50–70% — especially when not thawed properly or frozen prematurely. According to guidance from the NIH and peer-reviewed standards, this can significantly compromise the therapeutic effect. At SCTE, our approach is different:- We use fresh, lab-expanded umbilical cord mesenchymal stem cells.
- We control the full chain of custody — from donor screening to thawing.
- We verify viability with certified digital cell counting tools at the time of application.
Learning from a Misleading Study
In 2023, Nature Medicine published a study concluding that MSC infusion did not benefit certain patients. But the study had two critical issues:- The cell dose used was too low for meaningful therapeutic impact.
- Viability of the stem cells was never measured.
Scientific Backing for Our Approach
NIH Clinical Review “Cell viability is a critical quality attribute measured throughout the manufacturing process… ensuring their quality, consistency, and safety.” (NIH) ISSCR Guidelines Stem cell therapies must adhere to high standards of reproducibility and safety, with special focus on cell viability and potency. (ISSCR)Bottom Line
You shouldn’t have to guess whether your treatment will work. At SCTE, you won’t. We deliver verified, high-viability stem cells backed by science, technology, and medical integrity. Because in regenerative medicine, every living cell counts — and we make sure every one of them matters.Citations
- National Institutes of Health (NIH). “Product Quality Standards in Regenerative Medicine.” This peer-reviewed article outlines how stem cell viability is a critical quality attribute that must be monitored throughout manufacturing to ensure consistency, safety, and therapeutic effect.
- International Society for Stem Cell Research (ISSCR). “Guidelines for Stem Cell Research and Clinical Translation.” These global standards stress the importance of rigorous testing for cell potency and viability to maintain reproducibility and patient safety in clinical stem cell applications.
- Nature Medicine (2023). “Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial.” This large, multicenter trial found no significant difference between stem cell-based injections and corticosteroids, likely due to insufficient cell dose and unmeasured viability — not an inherent failure of stem cell therapy.